Addressing stability issues of vildagliptin: Method optimization and validation for accurate analysis in human plasma
Santosh Tawari1, Ujashkumar Shah1
1Nootan Pharmacy College, Sankalchand Patel University, Visnagar, Gujarat, India.
Biomedical Chromatography : BMC
|August 21, 2024
Summary
This study introduces a novel method to stabilize vildagliptin in human plasma using malic acid, improving drug quantification. The validated assay offers high accuracy and precision for therapeutic drug monitoring and pharmacokinetic studies.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Analysis
Background:
- Vildagliptin stability in biological matrices presents challenges for accurate quantification.
- Existing analytical methods may suffer from degradation issues, impacting reliability.
Purpose of the Study:
- To develop and validate a novel, stability-enhanced analytical method for vildagliptin quantification in human plasma.
- To address the limitations of current methods concerning vildagliptin degradation.
Main Methods:
- Incorporation of malic acid to stabilize vildagliptin in human plasma.
- Optimization of liquid chromatography (LC) using a C18 column with acetonitrile and ammonium trifluoroacetate.
- Detection and quantification via electrospray ionization (ESI) tandem mass spectrometry (MS/MS).
Main Results:
- The method effectively stabilized vildagliptin, preventing degradation.
- High accuracy (97.30%-104.15%) and precision (0.32%-3.09% CV) were achieved.
- Shortened run time (~2.2 min) and a wide linear range (1.00-851.81 ng/mL) were demonstrated.
Conclusions:
- The developed method overcomes vildagliptin stability issues in human plasma.
- Its efficiency, reproducibility, and speed make it suitable for therapeutic drug monitoring, bioequivalence, and pharmacokinetic studies.
More Related Videos
Related Concept Videos
01:09One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
228
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
228
01:23Dipeptidyl Peptidase 4 Inhibitors
179
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
179
01:20Determination of Michaelis Constant and Maximum Elimination Rate
75
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
75
01:15Data Validation
153
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
153
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
104
01:12Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241